{
  "ticker": "HPC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959996",
  "id": "02959996",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250619",
  "time": "0949",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250619/pdf/06kwzblzj2qxvl.pdf",
  "summary": "### Summary of ASX Announcement (HPC - 19 June 2025):  \n\n- **Net Sales**: US$308,000 in May 2025 (+34% MoM, +18% YoY) \u2014 highest monthly sales in CY25.  \n- **Gross Margin**: 66.5%, driven by high-margin SKUs.  \n- **EBITDA Loss**: ~US$127,000 (improved 29% MoM; fifth consecutive month of improvement).  \n- **Cash Balance**: US$1.9m as of 18 June 2025.  \n- **New Products**: Two SKUs targeting gut/brain health to launch in Q3 CY25.  \n\n**Material Impact**: Continued sales growth, margin strength, and EBITDA trend toward breakeven; cash position supports near-term operations.",
  "usage": {
    "prompt_tokens": 1481,
    "completion_tokens": 172,
    "total_tokens": 1653,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-19T00:49:05.648274"
}